Acelyrin, Inc. (SLRN) Tops Q3 EPS by 70c

Acelyrin, Inc. (NASDAQ: SLRN) reported Q3 EPS of ($0.49), $0.70 better than the analyst estimate of ($1.19).

For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.

You May Also Be Interested In

• eToro Group (ETOR) Reiterated at Market Outperform by Citizens as EBITDA Rises 9%
• Adecoagro S.A. (AGRO) Misses Q2 EPS by 63c
• Chicago Atlantic Real Estate Finance (REFI) PT Lowered to $16 at Citizens Post Q2 Results